![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.25 | 1.59% | 16.00 | 15.50 | 16.50 | 16.00 | 15.75 | 15.75 | 221,925 | 08:09:01 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 5.55 | 14.36M |
Date | Subject | Author | Discuss |
---|---|---|---|
27/10/2016 18:19 | Happyman7 - "I note that the 'clown' or some other looney has disliked me for the above post,who cares." LOL. It just gets better on the main thread. Happyman7 you weren't quick enough deleting your post from the main thread. Hello Lukead/happyman7. How many different aliases have you got? I'm beginning to think it's just you and elrico. I thought I was supposed to be the troll, looney etc. LOL. Entertainment at it's very best. Nighty night don't let the lower highs and lower lows bite. | ![]() michaelmouse | |
27/10/2016 18:11 | Previous fatties need not apply ! | ![]() whl2 | |
27/10/2016 18:09 | hey ho, i need to lose weight | happyman7 | |
27/10/2016 17:10 | You're getting confused ladies and gentleman. You seem to think that my comments are somehow driving down the share price. I'm flattered of course, but this is not the case. The ultimate fate of OptiBiotix and any other company is in its own hands. I have merely pointed out a few pertinent facts and some predictions that have proven to be accurate (so far). Let's hope IC sell a few more copies over the weekend because otherwise it's another lower high and......that's right........a lower low. I'm beginning to believe these chart theories, a perfect rolling top has formed.:) Next stop?? | ![]() michaelmouse | |
27/10/2016 16:21 | Hi Tightfist, thanks for the comment. Ive narrowed it down to chocolate and vanilla shakes, banana is ok but the wife isn't keen. Haven't kept exact diary but I think we have been on it about 11 weeks or so. Just have a shake in the car on way to work and one at lunch, I also have a snack bar( peanut) in the afternoon and then a meal at night. Only vice is a bacon and sausage butty on Sunday morning( what's the point of living without bacon?) | ![]() 1bokke | |
27/10/2016 16:11 | elrico, at least she gives you some credit, mine appears to believe I can't do anything right! | ![]() fozdad | |
27/10/2016 16:09 | I have written the post below on the michaelmouse thread and do hope all buy into it. 'ok guys, I think we can safely say that Mouse is weirdly obsessed with Opti now. With this type of person you need to stop interacting and just allow him to continue on his own. If you keep responding, he will keep writing. If nobody responds then in x number of months/years (I know it is a long time but this bloke is a one off) his enthusiam for the stock will wane. So everyone, just stop writing on this thread going forward, it is that simple.' | ![]() uzbek1 | |
27/10/2016 16:06 | ok guys, I think we can safely say that Mouse is weirdly obsessed with Opti now. With this type of person you need to stop interacting and just allow him to continue on his own. If you keep responding, he will keep writing. If nobody responds then in x number of months/years (I know it is a long time but this bloke is a one off) his enthusiam for the stock will wane. So everyone, just stop writing on this thread going forward, it is that simple. | ![]() uzbek1 | |
27/10/2016 16:02 | Top post rb1 - excellent explanation! | ![]() someuwin | |
27/10/2016 16:00 | Foz - as a division...as is slimbiome IP. I really should stop walking and typing. My wife says I can't multi task. | elrico | |
27/10/2016 15:53 | riskybusiness1 - "we get money from those who want to manufacture and those who want to sell costing us nothing." Really? So why have they (bought) spent money buying 51% of GoFigure and £400,000 developing one product in SkinBiotix? | ![]() michaelmouse | |
27/10/2016 15:41 | Quite honestly it seems everything is going better than planned. It's a shame the market is sentiment driven. Opti are in a position far greater than they were when the share price was 80p+. The value will be realised here in the coming years. (You only lose money by selling at less than you paid - just a reminder to some).The reason valios strain was bought by chr Hansen recently for 80m was because of sales, publications and a brand (LGG). This particular strain is a normal probiotic, it had not been selectively screened for its health benefits. They understand that it produces certain health benefits through its clinical data, however the mechanism of action is not understood. Basically they know it does good but have no idea how - basic probiotic. Taking that in to consideration and looking at what opti are aiming and succeeding in doing you begin to realise how much value this has. Optis first product they have screened 100s of strains. These would then be narrowed down to the best 3 for gut survivability and of course cholesterol reducing effect. This means opti have created a next generation probiotic by selectively targeting the microbiome. If you look at how much a basic probiotic can be worth such as LGG compared to one that is fully understood - you can't because they don't exist. The market is finding it hard to value because of this.Even following this, opti have now created a sugar that feeds the cholesterol probiotic strain and has proven an increase in its growth rate. This increase in growth rate increases the efficacy of the product threefold. This link between increasing the growth rate with efficacy of health benefit is revolutionary to medical science as a whole, let alone the probiotics market. If you understand all this you realise things haven't even started yet. The product we already have could be a natural statin replacement. Obviously from proof of concept to this stage will take longer than a few years. If this was a pharma company and recorded these achievements the value would be 6-700£m plus. If you realise that this whole platform has been designed for pharma you understand a great deal of value will come from this if you are a long term holder. This has to be built first, but if you see all the routes to market with s business plan of licensing its technology you realise costs will be minimal - we get money from those who want to manufacture and those who want to sell costing us nothing. Closest you'll get to printing money. The intel inside approach example given by soh yday was very good. Why tie up with one company when you can get revenues using the ip in all types of distributors across the world in multiple formulations. | ![]() riskybusiness1 | |
27/10/2016 15:32 | Thanks for post Adnanwolf, good to hear your positive view. Yesterdays RNS is huge I think. I like also the analogy of "Intel Inside". We are seeing already this concept with the Go figure product "slimbiome inside"! This approach is well thought out and should lead to a multitude of diverse applications across a whole range of products.... in fact I can't begin to imagine what might transpire as Opti are so diverse in their product line already.. GLA ! | ![]() nicktopten | |
27/10/2016 15:25 | Lol. "Your history gives you away!" Erh....he gave himself away. He declared he was a shareholder. Pollock! | elrico | |
27/10/2016 15:24 | elrico - What does SOH is a lair mean? and I've never heard the expression "hate blinds the bind". ;) You're a bit nuts and getting very boring. I'm putting you back on filter since you keep uttering total gibberish. | ![]() michaelmouse | |
27/10/2016 15:14 | From the CEO yesterday: "...Investors should also note from the RNS that our weight management division is now profitable, as previously stated to the market the costs of our sugar division is largely covered by partnering deals, and we are now commercialising products in our Optiscreen division. This means that despite all this activity we still have a similar amount of funds to announced at the interims." | ![]() someuwin | |
27/10/2016 15:14 | Your £2m figure was wrong, wasn't it. Even allowing for my own error, I was still c£600k closer then your made up figure. So even from my single-cell I have calculate OPTI are 2 years away from needing a cash injection. Even then we must first assume; 1: SOH is a lair (don't confuse him with the AVN CEO). 2: GoFigure reverses a so called satturated market. 3: There is no IPO with 18 month* * You do realise OPTI will almost certainly get a cash injection for their part in the placing! Of course you don't because you don't understand how it works....despite the best efforts of people more clued up than you. I find it odd you continue to promote your blog on a thread you keep taking a kicking from. What's the saying? The definition of stupid is repeating the same mistakes and expecting a different result! Simply stating a guess as fact (placing) without firm analysis how you derived at the assumption/guess is hardly credible on the back of the kicking you are getting from your darling growth stocks Avanti 250p to 24p and Trakm8 360p to 155p. Hate blinds the bind! | elrico | |
27/10/2016 15:10 | elrico, ref 16893, the RNS said that the Weight Management Division is profitable, I very much doubt that the whole company is profitable! | ![]() fozdad | |
27/10/2016 15:10 | Oh my lord it's the return of Dr Adnan Wolf on the main thread. Things are getting to desperation point. LOL. Yes that's right Doctor you'll soon be prescribing shed-loads of Opti products. Beware that conflict of interest. You being a shareholder and all that ;) Your posting history gives you away. Coincidentally one of your first posts was mentioning a bloodbath in trakm8 shares. Strange since it was your only post and you claimed to be a holder? Pillock. | ![]() michaelmouse |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions